KAIROS PHARMA LTD (KAPA)
US48301N1046 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to KAPA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.18. This target is 507.95% above the current price.
KAPA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KAPA.
In the previous month the buy percentage consensus was at a similar level.
KAPA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-10-14 | EF Hutton | Initiate | Buy |